PROMAZINE—IPRONIAZID: A BRIEF REPORT
DOUGLAS VANN M.R.C.S.1
1 City Chambers, Civic Center, Canberra, Australia.
The effects of Marsilid cannot be assessed separately and objectively in a few cases also receiving other therapy, but improvement in the majority was unexpectedly rapid and greater than that shown on a previous regimen. Marsilid dosage was begun at a lower level than that given by Smarr, Wolf and Pressman(1) whilst the response to corticosteriod therapy in case no. 5 was similar to that reported by Trethowan and Shand(2,3) in chlorpromazine–jaundice.
